AngioDynamics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AngioDynamics, Inc. on August 14, 2020, reporting an event that occurred on August 11, 2020. The company is incorporated in Delaware and its common stock trades on the NASDAQ Global Select Market under the symbol ANGO.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director. Kevin Gould announced his intention to retire from the Board of Directors. His retirement is effective as of the date of the 2020 annual meeting of shareholders, currently scheduled for October 13, 2020. The company stated that Mr. Gould's retirement was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on future performance, or specific risk factors beyond the standard disclosure of the director's departure.
Key Facts for Investors to Verify
- Kevin Gould's retirement from the Board of Directors is scheduled to take effect at the annual meeting on October 13, 2020.
- The departure is voluntary and not related to any disagreement with the company.
- Investors should monitor subsequent filings for the election of a new director to fill the vacancy.